Harnessing prostaglandin E2 signaling to ameliorate autoimmunity

Trends Immunol. 2023 Mar;44(3):162-171. doi: 10.1016/j.it.2023.01.004. Epub 2023 Jan 25.

Abstract

The etiology of most autoimmune diseases remains unknown; however, shared among them is a disruption of immunoregulation. Prostaglandin lipid signaling molecules possess context-dependent immunoregulatory properties, making their role in autoimmunity difficult to decipher. For example, prostaglandin E2 (PGE2) can function as an immunosuppressive molecule as well as a proinflammatory mediator in different circumstances, contributing to the expansion and activation of T cell subsets associated with autoimmunity. Recently, PGE2 was shown to play important roles in the resolution and post-resolution phases of inflammation, promoting return to tissue homeostasis. We propose that PGE2 plays both proinflammatory and pro-resolutory roles in the etiology of autoimmunity, and that harnessing this signaling pathway during the resolution phase might help prevent autoimmune attack.

Keywords: PGE(2); T cells; anti-inflammatory; inflammation; macrophage; proinflammatory.

Publication types

  • Review
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Autoimmune Diseases*
  • Autoimmunity*
  • Dinoprostone / metabolism
  • Humans
  • Signal Transduction
  • T-Lymphocyte Subsets / metabolism

Substances

  • Dinoprostone